Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Optic Nerve Glioma × Endostatins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Nasopharyngeal Carcinoma 7 Colorectal Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma 2 Recurrence 2 Neoplasms 2 Head and Neck Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Solid Tumors 1 Optic Nerve Glioma 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroblastoma 1 Meningeal Carcinomatosis 1 Melanoma 1 Lymphoma, T-Cell 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Organoids 1

Interventions

Carboplatin 12 Temozolomide 9 Filgrastim 8 Radiotherapy 5 Etoposide 5 Vincristine 4 Granulocyte Colony-Stimulating Factor 4 etoposide phosphate 3 O(6)-benzylguanine 3 Irinotecan 3 Ifosfamide 3 Busulfan 3 Topotecan 2 Radiotherapy, Intensity-Modulated 2 Peripheral Blood Stem Cell Transplantation 2 Oxaliplatin 2 Melphalan 2 Lenalidomide 2 Cyproheptadine 2 Cyclophosphamide 2 Cilengitide 2 veliparib 1 trioctyl phosphine oxide 1 sodium thiosulfate 1 sargramostim 1 romidepsin 1 pomalidomide 1 pazopanib 1 lonafarnib 1 laromustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡